Drugs / DDP
last change Jan 2022 re-read 2 minutes ago

DDP

Developed for
nasopharyngeal carcinoma

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02237924 Comparator Sep 2014 → Sep 2021 nasopharyngeal carcinoma First Affiliated Hospital of Guangxi Medical University Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DDP ClinicalTrials.gov intervention name — accepted as the source's own label NCT02237924
Route Intravenous intravenous infusion over 2 hours” NCT02237924